These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 8175923)

  • 1. The processing pathway of prelamin A.
    Sinensky M; Fantle K; Trujillo M; McLain T; Kupfer A; Dalton M
    J Cell Sci; 1994 Jan; 107 ( Pt 1)():61-7. PubMed ID: 8175923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleoplasmic localization of prelamin A: implications for prenylation-dependent lamin A assembly into the nuclear lamina.
    Lutz RJ; Trujillo MA; Denham KS; Wenger L; Sinensky M
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):3000-4. PubMed ID: 1557405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamin A precursor is localized to intranuclear foci.
    Sasseville AM; Raymond Y
    J Cell Sci; 1995 Jan; 108 ( Pt 1)():273-85. PubMed ID: 7738105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An antibody which specifically recognizes prelamin A but not mature lamin A: application to detection of blocks in farnesylation-dependent protein processing.
    Sinensky M; Fantle K; Dalton M
    Cancer Res; 1994 Jun; 54(12):3229-32. PubMed ID: 8205544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoprenylation is required for the processing of the lamin A precursor.
    Beck LA; Hosick TJ; Sinensky M
    J Cell Biol; 1990 May; 110(5):1489-99. PubMed ID: 2335559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of prelamin A but not mature lamin A confers sensitivity of DNA biosynthesis to lovastatin on F9 teratocarcinoma cells.
    Sinensky M; McLain T; Fantle K
    J Cell Sci; 1994 Aug; 107 ( Pt 8)():2215-8. PubMed ID: 7983180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the purpose of prelamin A processing.
    Davies BS; Coffinier C; Yang SH; Barnes RH; Jung HJ; Young SG; Fong LG
    Nucleus; 2011; 2(1):4-9. PubMed ID: 21647293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prelamin A endoproteolytic processing in vitro by recombinant Zmpste24.
    Corrigan DP; Kuszczak D; Rusinol AE; Thewke DP; Hrycyna CA; Michaelis S; Sinensky MS
    Biochem J; 2005 Apr; 387(Pt 1):129-38. PubMed ID: 15479156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirements for efficient proteolytic cleavage of prelamin A by ZMPSTE24.
    Barrowman J; Hamblet C; Kane MS; Michaelis S
    PLoS One; 2012; 7(2):e32120. PubMed ID: 22355414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of nuclear lamin proteins by a mevalonic acid derivative occurs in reticulocyte lysates and requires the cysteine residue of the C-terminal CXXM motif.
    Vorburger K; Kitten GT; Nigg EA
    EMBO J; 1989 Dec; 8(13):4007-13. PubMed ID: 2686979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson-Gilford progeria syndrome.
    Mallampalli MP; Huyer G; Bendale P; Gelb MH; Michaelis S
    Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14416-21. PubMed ID: 16186497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenylated prelamin A interacts with Narf, a novel nuclear protein.
    Barton RM; Worman HJ
    J Biol Chem; 1999 Oct; 274(42):30008-18. PubMed ID: 10514485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro assay and characterization of the farnesylation-dependent prelamin A endoprotease.
    Kilic F; Dalton MB; Burrell SK; Mayer JP; Patterson SD; Sinensky M
    J Biol Chem; 1997 Feb; 272(8):5298-304. PubMed ID: 9030603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mislocalization of prelamin A Tyr646Phe mutant to the nuclear pore complex in human embryonic kidney 293 cells.
    Pan Y; Garg A; Agarwal AK
    Biochem Biophys Res Commun; 2007 Mar; 355(1):78-84. PubMed ID: 17291448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttranslational modification of proteins by isoprenoids in mammalian cells.
    Maltese WA
    FASEB J; 1990 Dec; 4(15):3319-28. PubMed ID: 2123808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prelamin A, Zmpste24, misshapen cell nuclei, and progeria--new evidence suggesting that protein farnesylation could be important for disease pathogenesis.
    Young SG; Fong LG; Michaelis S
    J Lipid Res; 2005 Dec; 46(12):2531-58. PubMed ID: 16207929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerin-prelamin A interplay in human fibroblasts.
    Capanni C; Del Coco R; Mattioli E; Camozzi D; Columbaro M; Schena E; Merlini L; Squarzoni S; Maraldi NM; Lattanzi G
    Biol Cell; 2009 Sep; 101(9):541-54. PubMed ID: 19323649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CaaX motif is required for isoprenylation, carboxyl methylation, and nuclear membrane association of lamin B2.
    Kitten GT; Nigg EA
    J Cell Biol; 1991 Apr; 113(1):13-23. PubMed ID: 2007618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An accumulation of non-farnesylated prelamin A causes cardiomyopathy but not progeria.
    Davies BS; Barnes RH; Tu Y; Ren S; Andres DA; Spielmann HP; Lammerding J; Wang Y; Young SG; Fong LG
    Hum Mol Genet; 2010 Jul; 19(13):2682-94. PubMed ID: 20421363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The farnesyl protein transferase inhibitor BZA-5B blocks farnesylation of nuclear lamins and p21ras but does not affect their function or localization.
    Dalton MB; Fantle KS; Bechtold HA; DeMaio L; Evans RM; Krystosek A; Sinensky M
    Cancer Res; 1995 Aug; 55(15):3295-304. PubMed ID: 7614464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.